CT Coronary Angiography and Cardiac CT

CT coronary angiography (CTCA) and broader cardiac CT protocols represent a major category of noninvasive cardiovascular imaging, used to evaluate coronary artery anatomy, calcium burden, and structural heart features without the procedural risks of catheter-based techniques. This page covers the technical basis of these methods, the clinical situations in which they are ordered, and the boundaries that determine when they are appropriate versus when other modalities take precedence. Understanding these tools in context requires familiarity with cardiology's diagnostic landscape and the regulatory context for cardiology that governs imaging appropriateness criteria.

Definition and Scope

Cardiac CT encompasses a family of imaging protocols that use X-ray computed tomography—often paired with intravenous iodinated contrast and electrocardiographic (ECG) gating—to generate high-resolution images of heart structures and coronary vessels. The two most clinically significant variants are:

CT Coronary Angiography (CTCA / CCTA): Contrast-enhanced imaging of the coronary arteries acquired during a single breath-hold, typically 10–15 seconds, to assess lumen narrowing, plaque morphology, and vessel patency.

Coronary Artery Calcium Scoring (CACS): A non-contrast scan that quantifies calcified atherosclerotic plaque in coronary vessels using the Agatston score, a validated numerical scale established in published research by Agatston et al. (1990) and integrated into risk-stratification guidelines by the American College of Cardiology (ACC) and American Heart Association (AHA).

Additional cardiac CT protocols include CT-derived fractional flow reserve (CT-FFR), whole-heart structural evaluation for valve and congenital anatomy, and pre-procedural planning scans before transcatheter interventions such as transcatheter aortic valve replacement.

The American College of Radiology (ACR) publishes Appropriateness Criteria that classify cardiac CT indications by clinical scenario and evidence strength, providing a structured framework for ordering decisions (ACR Appropriateness Criteria).

How It Works

CTCA relies on four integrated technical components:

ECG synchronization: Images are acquired either prospectively (triggered at a single cardiac phase) or retrospectively (throughout the cycle, allowing functional analysis). Prospective triggering reduces radiation dose significantly compared to retrospective gating.
Contrast timing: Iodinated contrast is injected intravenously and tracked by bolus-tracking software; acquisition begins when contrast density in the aortic root reaches a target threshold, typically 100–150 Hounsfield units.
Multidetector CT (MDCT) hardware: Modern scanners use 64-slice or higher detector configurations—with 256- and 320-detector systems available at advanced centers—enabling submillimeter spatial resolution (approximately 0.5–0.6 mm isotropic) and temporal resolution below 100 milliseconds per cardiac phase.
Post-processing: Dedicated workstations reconstruct curved multiplanar reformats (cMPR), maximum intensity projections (MIP), and volume-rendered images to display coronary anatomy in three dimensions.

Radiation exposure varies by protocol and patient body habitus. A prospectively gated CTCA delivers an effective dose of approximately 1–3 millisieverts (mSv) in optimized protocols, compared to 5–15 mSv for retrospectively gated acquisitions, according to published data reviewed by the Society of Cardiovascular Computed Tomography (SCCT) in its clinical practice guidelines (SCCT Guidelines).

Calcium scoring is performed without contrast and delivers an effective dose of approximately 1–3 mSv, making it one of the lower-dose structured cardiac imaging protocols available.

Common Scenarios

CTCA is ordered across a defined set of clinical presentations where noninvasive anatomic coronary assessment adds diagnostic value:

Chest pain evaluation in intermediate-risk patients: Patients presenting with stable chest pain and intermediate pre-test probability of obstructive coronary artery disease (CAD)—typically defined as 10–90% probability by validated tools such as the Duke Clinical Score or HEART Score—are a primary indication. The landmark PROMISE trial (2015, New England Journal of Medicine) enrolled over 10,000 patients and found CCTA-guided strategy to be comparable to functional testing in clinical outcomes, with a 34% reduction in unnecessary invasive catheterization.
Coronary anatomy clarification: When cardiac catheterization and angiography findings are ambiguous or when vessel origin anomalies are suspected, CTCA provides three-dimensional anatomic context that catheter-based projection angiography cannot deliver.
Pre-operative cardiac assessment: Structural cardiac CT is used before electrophysiology procedures, including pulmonary vein isolation for atrial fibrillation, to map pulmonary vein anatomy and left atrial dimensions.
Calcium scoring in asymptomatic patients: The 2019 ACC/AHA Primary Prevention Guidelines assign a Class IIa recommendation to coronary artery calcium scoring for intermediate-risk asymptomatic adults (7.5–20% 10-year ASCVD risk) when the decision to initiate statin therapy is uncertain (ACC/AHA 2019 Guideline on Primary Prevention).
Structural heart pre-procedure planning: CTCA and cardiac CT are standard of care before heart valve repair and replacement procedures to assess annular dimensions, vascular access, and calcification patterns.

Decision Boundaries

CTCA is not universally applicable, and clinical appropriateness depends on factors that limit image quality or alter the risk-benefit ratio:

When CTCA is preferred over invasive angiography: In stable patients with intermediate pre-test probability and no planned intervention, CTCA avoids the 1–2% minor complication rate and 0.1% major complication rate associated with diagnostic cardiac catheterization (as reported in ACC/NCDR registry data).

When CTCA is contraindicated or degraded:
- High resting heart rate: Rates above 65–70 beats per minute degrade temporal resolution; beta-blocker premedication is standard protocol in most centers.
- Severe coronary calcification: Extensive calcium causes blooming artifact that obscures luminal assessment. A calcium score above 400 Agatston units is widely cited as a threshold where CTCA diagnostic accuracy is substantially reduced.
- Renal insufficiency: Iodinated contrast is nephrotoxic; estimated glomerular filtration rate (eGFR) thresholds for safe administration are typically set at 30–45 mL/min/1.73 m², per institutional protocols informed by ACR contrast manual recommendations (ACR Manual on Contrast Media).
- Irregular cardiac rhythm: Atrial fibrillation and frequent ectopy compromise ECG-gated reconstruction, reducing diagnostic reliability compared to sinus rhythm acquisition.

CTCA versus cardiac MRI: Cardiac MRI provides superior tissue characterization—myocardial fibrosis, infiltrative disease, viability—without ionizing radiation, but lacks the spatial resolution to evaluate coronary lumen patency reliably. The two modalities are complementary rather than competitive, targeting different diagnostic questions.

CTCA versus nuclear cardiology: Nuclear cardiology protocols assess myocardial perfusion and functional ischemia, not coronary anatomy. A positive CTCA finding (stenosis ≥50% by diameter) does not confirm hemodynamic significance; CT-FFR analysis or functional testing is required to determine whether revascularization is physiologically warranted, as outlined in the FFRCT PLATFORM and ADVANCE registry publications.

The SCCT, ACR, and ACC collectively publish appropriateness criteria and technical standards that define acceptable use cases, minimum scanner specifications, and reader training requirements for cardiac CT programs in clinical practice.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)